The ELISA results showed that the acute AD patients exhibited higher plasma SFRP1, SFRP2, SFRP3, and SFRP4 levels and lower SFRP5 levels than the levels in the NAD group (Figures 1A–E). This evidence concerns the gene SFRP1 and Alzheimer disease.